Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15807 articles
Galectin-3 expression is prognostic in diffuse type gastric adenocarcinoma, confers aggressive phenotype, and can be targeted by YAP1/BET inhibitors.
Gal-3 (P=0.001) and N-stage (P=<0.001) independently prognostic for shorter OS.
»
06/05/17
DNA methylation of imprinted gene control regions in the regression of low-grade cervical lesions.
Probability of CIN1 regression negatively correlated with methylation at IGF2AS.
»
06/21/17
Impact of Disgust on Intentions to Undergo Colorectal Surgery.
Intentions to undergo colorectal surgery diminished in patients who experience disgust about stoma information.
»
10/13/18
Standard-dose osimertinib for refractory leptomeningeal metastases in T790M-positive EGFR-mutant non-small cell lung cancer.
Osimertinib 80 mg useful therapeutic option for refractory LM.
»
04/29/17
Folic acid supplement use and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a case-control study.
Women who used any folic acid-containing supplement had significantly decreased risk of breast cancer.
»
10/05/18
Large-scale profiling of serum metabolites in African American and European American patients with bladder cancer reveals metabolic pathways associated with patient survival.
Metabolic profile of serum samples might be used to assess risk progression in AA BLC.
»
08/14/18
Molecular changes during extended neoadjuvant letrozole treatment of breast cancer: distinguishing acquired resistance from dormant tumours
Dormant tumours continue to change during treatment whereas acquired resistant tumours more closely resemble their diagnostic samples.
»
01/07/19
Patients with metastatic renal cell carcinoma who benefit from axitinib dose titration: analysis from a randomised, double-blind phase II study
Current analyses identified potentially predictive factors.
»
01/07/19
Differences in tumor microenvironments between primary lung tumors and brain metastases in lung cancer patients: therapeutic implications for immune checkpoint inhibitors
Discordant responses to an ICI of lung cancer between primary lung lesion and brain metastases.
»
01/07/19
Radium-223 in asymptomatic patients with castration-resistant prostate cancer and bone metastases treated in an international early access program
Using radium-223 earlier in the disease course may enable patients to complete treatment.
»
01/07/19
< Prev
Next >